Researchers in Cardiff University propose to investigate the long-term safety of Liothyronine (T3) using records from the late Dr G Skinner’s clinic.  The study will use a data linkage approach that will enable researchers to analyse the patient data without knowing the identities of patients. Details of the study and, how patients can opt out of their data being included in the study, can be found in this document ..read more

We have sadly learned of the death of Dr Barry Durrant-Peatfield. Dr Peatfield was a trustee of Thyroid UK in the early days and without him, Thyroid UK would not be where we are today. He was a very lovely, kind and generous man who truly cared about his patients and who, in our opinion, saved a lot of lives and gave a quality of life back to many, many people who saw him. His books are his legacy. They help thyroid patients understand the condition and how to become well and so many patients in the future will be helped by reading them. We really do wish there were more doctors like him toda ..read more

Lyn Mynott, CEO of Thyroid UK, was interviewed by Aggie McCabe about why she set Thyroid UK up, what the issues are with thyroid diagnosis and treatment and the work they are doing for their #T3Campaign.  Aggie is a thyroid nutritionist, an emotional wellness coach and a fellow thyroid adventurer. Aggie regularly interviews people about various important nutritional issues and writes stories for her Instagram page that give people the information they need to become well again. We are so pleased that we managed to help Aggie in the beginning of her thyroid journey –  “Thyroid UK wil ..read more

We want to ensure that Integrated Care Boards follow the guidance rather than continue to refuse Liothyronine (T3) to patients who need it. Levothyroxine is the standard medication for hypothyroidism but not all patients have their symptoms resolved with this and liothyronine (T3) can, in some patients, make a world of difference to their symptoms. However, liothyronine needs to be prescribed by an endocrinologist, as per liothyronine guidance. Thyroid UK, along with other partner thyroid organisations published a new T3 Prescribing Report which shows that 58% of Clinical Commissioning Group ..read more

To raise awareness, we would like you, if you can, to make or buy some cakes or biscuits (these can be low sugar/gluten-free/vegan) and give them to family and friends with a note (in your own words) to say how thyroid disease is affecting you and asking them to visit the Thyroid UK website. In your note, you can put the web address of any page on our website that is relevant to you or just the home page so that they can look around for themselves to find some relevant facts about thyroid disease. They will then not only understand what has happened to you (or your family member or friend) bu ..read more

We are very pleased to tell you that we are partnering with an amazing organisation called The Wren Project. The Wren Project is a registered UK charity, founded in 2020, that works to support individuals with the emotional and mental impact arising from a diagnosis of autoimmune disease. Most people with thyroid disease have the autoimmune form – Hashimoto’s Disease (causing hypothyroidism) and Graves’ Disease (causing hyperthyroidism). Thyroid UK knows that many people are left undiagnosed and also that diagnosis can take a very long time. We think that working with The Wren Project wi ..read more

The Medicines and Healthcare products Regulatory Agency (MHRA) have published new guidance regarding levothyroxine The MHRA have just published new prescribing advice for healthcare professionals who prescribe levothyroxine due to reports of some patients experiencing symptoms on switching between different tablet products. Levothyroxine is usually a generic product i.e. a copy of a previous brand rather than a branded version.  There are several levothyroxine generics nowadays and this means that you may not be given the same generic every time you collect your prescription. The MH ..read more

Researchers in Cardiff University propose to investigate the long-term safety of Liothyronine (T3) using records from the late Dr G Skinner’s clinic.  The study will use a data linkage approach that will enable researchers to analyse the patient data without knowing the identities of patients. Details of the study and, how patients can opt out of their data being included in the study, can be found in this document ..read more

Recently the CMA levied fines of £84 million to those companies that caused a price hike for liothyronine, causing untold distress for many thyroid patients. Dr Peter Taylor has created a Government Petition requesting that an amount equivalent to a proportion of the fine (1-5%) is made available for thyroid research and support for patients with hypothyroidism. Can you imagine how much thyroid research can be done with £4,000,000??? I think it’s only right that some of that fine should go to thyroid research so do please sign this petition and let’s get it to 100,000 signatures so that it is ..read more

We have sadly learned of the death of Dr Barry Durrant-Peatfield. Dr Peatfield was a trustee of Thyroid UK in the early days and without him, Thyroid UK would not be where we are today. He was a very lovely, kind and generous man who truly cared about his patients and who, in our opinion, saved a lot of lives and gave a quality of life back to many, many people who saw him. His books are his legacy. They help thyroid patients understand the condition and how to become well and so many patients in the future will be helped by reading them. We really do wish there were more doctors like him ..read more